Theriva Biologics Inc Share Price Today: Live Updates & Key Insights
Theriva Biologics Inc share price today is $0.1937, up 4.36%. The stock opened at $0.1856 against the previous close of $0.1856, with an intraday high of $0.1937 and low of $0.1837.
Theriva Biologics Inc Share Price Chart
Theriva Biologics Inc
Theriva Biologics Inc Share Price Performance
Theriva Biologics Inc Institutional Holdings
Theriva Biologics Inc Market Status
Theriva Biologics Inc Fundamentals
Market Cap 6.38 M
PB Ratio 0.5779
PE Ratio 0.0868
Enterprise Value -1.54 M
Total Assets 38.24 M
Volume 1839115
Theriva Biologics Inc Company Financials
About Theriva Biologics Inc & investment objective
Company Information Theriva Biologics, Inc., a clinical-stage company, develops therapeutics to treat cancer and related diseases in areas of high unmet need in the United States. Its lead product candidate, VCN-01 (zabilugene almadenorepvec), a clinical stage oncolytic human adenovirus that is in Phase 1 clinical trials and Phase 2 VIRAGE trial for patients with pancreatic cancer, head and neck squamous cell carcinoma, ovarian cancer, colorectal cancer, and retinoblastoma. The company also develops VCN-11 for treating solid tumors; SYN-004 (ribaxamase), an oral capsule prophylactic therapy that is in Phase 1b/2a clinical trials for the prevention of acute graft-versus-host-disease (aGVHD) in allogeneic hematopoietic cell transplant (HCT); and SYN-020, a recombinant oral formulation of the enzyme intestinal alkaline phosphatase (IAP) for multiple gastrointestinal and metabolic indications. In addition, it develops clinical stage products, such as SYN-006 to prevent aGVH, clostridioides difficile infection, and microbiome damage in patients treated with carbapenem antibiotics; and SYN-007 for preventing antibiotic associated diarrhea with oral ß-lactam antibiotics. The company has a license agreement with Rasayana Therapeutics, Inc. to research, develop, manufacture, and commercialize any product that includes SYN-020, as well as a clinical trial agreement with Washington University School of Medicine in St. Louis to conduct a Phase 1b/2a clinical trial of SYN-004. Theriva Biologics, Inc. is headquartered in Rockville, Maryland.
Organisation Biotechnology
Employees 15
Industry Biotechnology
CEO Mr. Steven A. Shallcross CPA
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Theriva Biologics Inc FAQs
What is the share price of Theriva Biologics Inc today?
The current share price of Theriva Biologics Inc is $0.1937.
Can I buy Theriva Biologics Inc shares in India?
Yes, Indian investors can buy Theriva Biologics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Theriva Biologics Inc shares in India?
You can easily invest in Theriva Biologics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Theriva Biologics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Theriva Biologics Inc.
Can I buy fractional shares of Theriva Biologics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Theriva Biologics Inc?
Theriva Biologics Inc has a market cap of $6.38 M.
In which sector does Theriva Biologics Inc belong?
Theriva Biologics Inc operates in the Biotechnology sector.
What documents are required to invest in Theriva Biologics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Theriva Biologics Inc?
The PE ratio of Theriva Biologics Inc is 0.09 and the PB ratio is 0.58.